Actively Recruiting

Phase Not Applicable
Age: 35Years - 80Years
All Genders
Healthy Volunteers
ID06333067

Safety and Efficacy of SofWave Treatment to Lift Facial Lax Skin and Improve Facial Wrinkles Using Precise and Lift Applicators

Led by Sofwave Medical LTD · Updated on 2025-05-13

100

Participants Needed

2

Research Sites

4 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This clinical study is an open-label, non-randomized, single-arm prospective trial designed to evaluate the safety and effectiveness of the SofWave system in lifting facial lax skin and improving facial wrinkles. The study includes adults aged 35 to 80 who desire cosmetic improvement of the face, neck, submental area, or eyebrow region. The study is conducted at multiple centers and includes masked evaluation of treatment effects. Participants will receive one or two treatments on the face, neck, or submental area using the SofWave device with either the Lift or Precise applicators. Treatments are spaced 2 to 12 weeks apart based on investigator discretion and site scheduling availability. Treatment may be given immediately after enrollment and screening or at a later scheduled date. Participants will attend a follow-up visit approximately three months after their last treatment to assess results. At each visit, efficacy and safety evaluations will be performed following the study protocol. The main outcome measured is the improvement in the appearance of skin laxity at the 3-month post-treatment visit. The total participation duration includes enrollment, treatment visits, and one follow-up visit.

CONDITIONS

Brief Title

Treatment to Lift Facial Lax Skin and Improve Facial Wrinkles Using Precise and Lift Applicators

Who Can Participate

Age: 35Years - 80Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Healthy female and male subjects between the ages 35-80
  • Non-smoker
  • Fitzpatrick skin type I-VI
  • Desire to lift facial lax skin, neck and/or submental and/or eyebrow area and/or improve facial wrinkles
  • Able and willing to comply with all visits, treatments, and evaluation schedules
  • Able to understand and provide written informed consent
  • Women of child-bearing age must use reliable birth control for at least 3 months prior to enrollment
  • Agree not to undergo other facial cosmetic treatments for 3 months after last SofWave treatment
  • Stable weight over the last 12 weeks and during the study
Not Eligible

You will not qualify if you...

  • Pregnant, planning pregnancy, recently gave birth (less than 3 months), or breastfeeding
  • Active systemic or local infections
  • Active local skin disease affecting wound healing
  • Severe solar elastosis
  • Current smoker or history of heavy smoking (25+ cigarettes/day) in past 10 years
  • History of chronic drug or alcohol abuse
  • Excessive subcutaneous fat on cheeks
  • Significant scarring in treatment area
  • Severe or cystic facial acne, or use of Accutane in past 6 months
  • Metal stent or implant in facial area (dental implants/braces allowed)
  • Unable to understand protocol or provide informed consent
  • Recent cosmetic treatments in treatment area (facial skin-tightening, injectables, laser/light treatments, dermabrasion, peels, facelift, blepharoplasty, brow lift) within specified timeframes
  • Use of isotretinoin or oral retinoids in past 6 months; anti-platelet or anti-coagulant use in past 2 weeks
  • Any physical or mental condition making participation unsafe per investigator discretion

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

Treatment

Duration - Variable based on number and timing of treatments

Participants receive 1 to 2 face and/or neck and/or submental treatments using the SofWave system with the Lift and/or Precise applicators, spaced 2 to 12 weeks apart.

1 to 2 in-person treatment visits spaced 2 to 12 weeks apart

Follow-up

Duration - 3 months ± 2 weeks after last treatment

Participants return for one follow-up visit approximately 3 months after their last treatment to evaluate efficacy and safety.

1 follow-up visit (in-person)

Trial Site Locations

Total: 2 locations

1

Costal Skin & Eye Institute

La Mesa, California, United States, 91942

Actively Recruiting

2

Skin Wellness Dermatology Associates

Durham, North Carolina, United States, 27713

Actively Recruiting

Loading map...

Research Team

S

Shlomit Mann, MSc

R

Ruthie Amir, MD

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here